Case Studies & Testimonials

Read some testimonials left by patients and case studies of our previous trials.

You can plan a clinical trial meticulously but when you start a First-in-Human study prepare to be flexible!

Richmond Pharmacology has extensive experience of conducting First-in-Human clinical trials, including studies involving biologics, and we have a very experienced team on hand to help you. You can be sure we will rise to the occasion.

View Case Study

Data Management Case Study - April 09

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

Data Management Case Study - March 09

Timelines, Tight Timelines, And Even Tighter Timelines In A Phase I Environment.

View Case Study

The Richmond Pharmacology Japanese Team commits to a challenging study...and they deliver.

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

65 Subjects Vaccinated in 1 day

Recruitment can sometimes be a challenge, however the tighter the timelines and the larger the group required, the more Richmond Pharmacology rises to the challenge.

View Case Study

“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”

- Anonymous

“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”

- Anonymous

“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”

- Anonymous

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more

Dr Jorg Taubel, CEO of Richmond Pharmacology, features on the PM Live website, discussing clincial trials and COVID-19

August 11, 2020
Dr Jorg Taubel discusses some of the steps taken at Richmond Pharmacology to ensure clinical trials can continue to operate at a high standard throughout the COVID-19 pandemic.
Read more